More than half of malaria drugs in west Africa 'sub-standard quality,' says UNODC

NewsGuard 100/100 Score

VOA News reports that fake pharmaceuticals pose a greater risk to stability and human security in West Africa than illegal drug trafficking, according to U.N. Office Against Drugs and Crime report. More than half of the malaria medication available in West Africa is of "sub-standard quality," according to U.N. estimates, VOA News writes, adding, "West Africa has the highest estimated rate of malaria on the continent, with nearly 98 million cases of malaria per year."

"According to studies available, 50 percent of malaria tablets available in West Africa are fake, or they contain 20 percent of the active ingredient." Antonio Mazzitelli, the regional representative of the U.N. Office Against Drugs and Crime, said (Thomas, 7/10).

In related news, Ghana's Food and Drugs Board (FDB) recently warned the public about the presence of fake Coartem, a drug used to treat malaria, Joy Online reports. The FDB "has confiscated 150 packs of the product from nine wholesale and retail pharmacies involved in the distribution and sale of the fake products," writes the news service.

Joseph Bennie, an FDB officer, said the board has altered its internal mechanisms to more quickly and efficiently identify counterfeit goods on the local market and said retailers who find them should contact the FDB or the Pharmacy Council (7/10).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Ministers of Health commit to accelerated action against malaria in Africa